Vital Therapies Initiates Liver Stabiliza... ( SAN DIEGO Oct. 1 /- Vital Therapies I...)

Vital Therapies Initiates Liver Stabilization Trial

Date:10/1/2009

SAN DIEGO, Oct. 1 /PRNewswire/ -- Vital Therapies, Inc. (VTI), today announced that the first subject has been enrolled in a pivotal trial of its ELAD human cell-based liver assist system at California Pacific Medical Center (CPMC) in San Francisco. Todd Frederick, MD, Director of Liver Support Services, is the principal investigator for the trial at CPMC.

It is anticipated that up to 20 leading academic liver centers in the United States and Europe will take part in the SILVER (Stabilization In LiVER disease) study. The SILVER protocol allows for enrollment of patients with chronic liver disease who have recently suffered an acute event leading to moderate to severe liver failure, as measured by the Model for End Stage Liver Disease score (MELD). MELD score is widely accepted as an indicator of liver function.

The SILVER Trial is focusing on stabilization of liver disease so patients can either recover with their own liver intact or live long enough for a liver transplant. Liver transplantation is the only therapy proven to affect survival of liver failure patients. However the shortage of donor livers and the high cost of transplantation create a need either to support regeneration of the patient's own liver or to maintain sufficient liver function until a transplant organ becomes available. This study evaluates whether ELAD can provide this support.

For more details on the SILVER Trial, please go to www.clinicaltrials.gov

More than 120 patients have so far been treated with ELAD in six clinical trials in the United States, United Kingdom and China. An application for approval to market ELAD in China was filed in September 2007 after a pivotal clinical trial in China. This application is under review by China's SFDA.

VTI is also operating a compassionate use program with cost recovery in the United States, United Kingdom and Singapore.

About Vital Therapies, I
'/>"/>

SOURCE Vital Therapies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2
Related medicine news :

1. Sexually satisfied women have better general well-being and more vitality
2. New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical
3. Disability Advocates Call-Out Governor Schwarzenegger for Honoring Mother-In-Law While Cutting Vital Services
4. The Vitality Group Joins Efforts to Improve Health of U.S. Workforce
5. Emergency Preparedness Simulation Scenarios Developed for Disaster Training Utilizing Laerdals VitalSim(TM) Product Line
6. Frost & Sullivan: First Responders Communication Interoperability - A Vital Need for Life-Saving Services
7. Flintec Load Cell Design Helps to Create Vital Medical Solutions
8. Add Years to Your Life: Sign up for the AARP(R)/Blue Zones(R) Vitality Project to Be a Part of 6 Weeks to Longevity Kicking off on September 8th
9. Patient perception is vital when reporting medical errors
10. Vitality Health LLC Joins HealthySkinPortal Network
11. Gene vital to brains stem cells implicated in deadly brain cancer

Post Your Comments:

(Date:5/18/2013)... FL (May 18, 2013) There are significant ... commonly used to diagnose or treat gastrointestinal problems, ... (DDW). , A study by New York ... more objective testing may substantially reduce the cost ... Although GERD is believed to affect nearly 25 ...

(Date:5/18/2013)... May 18, 2013 Today, Zane ... insurance agents’ role in Marketplaces . Zane Benefits, ... employer sponsored health benefits, is the leader in ... health reimbursement arrangements . , According to ... Human Services (HHS) recently released a much-anticipated statement ...

(Date:5/18/2013)... NY (PRWEB) May 18, 2013 After working ... efforts, SizeItUp formally announced the integration of the ... 2012 Hyundai Genesis is set to stun the automobile market ... style. 2012 Hyundai Genesis is marked as the latest entry ... heads the vehicles lined up for the year 2013. ...

(Date:5/18/2013)... AL (PRWEB) May 18, 2013 Although ... malignant tumors, the association between obesity and esophageal adenocarcinoma, ... for other obesity-related tumors. As reported on ... people are almost twice as likely as those of ... Although the relationship between obesity and esophageal cancer is ...

(Date:5/18/2013)... May 18, 2013 Show And Go Training, ... various different training systems that is all about is getting ... the attention of http://ShowAndGoTrainingReview.com ’s Stan Stevenson, prompting ... is a unique “four phase system” designed to make you ... of time spent working out in the gym. The training ...

Breaking Medicine News(10 mins):Health News:New research identifies practice changes to improve value and quality of GI procedures 2 Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2 Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3 Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4 Health News:Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis 2 Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2 Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3 Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2

[0] New research identifies practice changes to improve value and quality of GI procedures [0] Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces [0] Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis [0] hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer [0] Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed

... for Everyone , Not all patients can tolerate ... can help physicians calculate the epirubicin dose associated with ... , Oncologists frequently use anthracyclines, including epirubicin and doxorubicin, ... lasting heart problems in a substantial number of patients. ...

... 6.9 percent sequentially - Q2 GAAP net profit ... - Case shipments of 54,870 increase 6.0 percent sequentially ... SANTA CLARA, Calif., July 29 Align,Technology, Inc. (Nasdaq: ALGN ... ended June 30, 2008., Total net revenues for the second ...

... projected ... ... of,high-quality ceramic solutions for the medical device industry, announced,today that, in ... on unit shipments to the orthopaedic,brachytherapy and electro-implantable market segments., ...

... FACP, FACEP (E), Executive,Director, American Public Health Association, ... Association strongly urges U.S. House members to vote ... Food and Drug Administration (FDA),the authority to regulate ... for more than 400,000 deaths each,year and costs ...

... of matted protein, researchers say , , TUESDAY, July 29 (HealthDay ... clogging "tangles" in the brain cells of people with Alzheimer,s ... studies are necessary to confirm whether the medication is as ... needs to be given as part of a cocktail of ...

... ... Future Costs Can Be Avoided with Proper Treatment and Prevention ... Initiatives, NEW BRUNSWICK, N.J., ... on New,Jersey,s economy of the most common chronic diseases is calculated to be,$39 billion. In ...

Also in the July 29 JNCI Align Technology Announces Second Quarter Fiscal 2008 Results C5 Medical Werks Reaches Million Mark in Components Shipped APHA Urges House to Protect Health of Americans by Passing Tobacco Legislation 'De-Tangling' Alzheimer's Drug Shows Promise Annual Economic Impact of Chronic Disease on New Jersey Economy Is $39 Billion

(Date:5/17/2013)... Lakeland Industries, Inc. (NASDAQ: LAKE ), ... healthcare and to first responders on the federal, state ... the fiscal 2013 fourth quarter and year ended January ... market close and will conduct a conference call on ... (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ) The call ...

(Date:5/17/2013)... Therapeutics, Inc. (Nasdaq: OREX ) today announced that ... Healthcare Conference in New York . The ... 11 a.m. Eastern Time. To listen to the live webcast ... Relations section of the Company,s Web site at www.orexigen.com ... the event. About Orexigen® Therapeutics Orexigen Therapeutics, ...

(Date:5/17/2013)... and CAMBRIDGE, Mass., May 17, 2013 Shareholder ... purchaser of Aveo Pharmaceutical, Inc. (NASDAQGS: AVEO) securities has ... the District of Massachusetts . The ... violated the Securities Exchange Act of 1934 (the "Exchange ... (the "Class Period"). (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ) ...

Breaking Medicine Technology:Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2 Aveo Pharmaceuticals, Inc. Sued by Investor 2 Aveo Pharmaceuticals, Inc. Sued by Investor 3

[0] Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call [0] Orexigen Therapeutics to Present at the UBS Global Healthcare Conference [0] Aveo Pharmaceuticals, Inc. Sued by Investor

... for Type 2 Diabetes -, HAYWARD, Calif., ... on the discovery and development of,proprietary new medicines ... it has dosed the first cohort of healthy ... a potential first-in-class treatment,for type 2 diabetes., ...

... Columbia, March 25, Astellas Pharma US, Inc. and ... ; TSX: COM) announced the first,pivotal Phase III ... was published today in Circulation,the official journal of ... known as the Atrial arrhythmia Conversion Trial (ACT ...

Cached Medicine Technology:Metabolex Initiates Phase 1 Trial of MBX-2982 2 Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm 2 Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm 3 Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm 4 Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm 5

Metabolex Initiates Phase 1 Trial of MBX-2982 Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm

Classic Trial Frames UB3 that has long set the standard....

... This quality Universal Trial Frame comes at a very attractive ... Temple angle, Temple length 4 1/8" to 5 1/2" ... angle 0 to 30, PD adjustable 24 to 40mm ... Axial calibration on each lens: left - 120 to 0 ...

Sickle blade. Flat stock myringotomy blade....

... offer the superior cutting advantages of ... the exclusive Rib-Back design for greater ... producer offer the wide selection of ... Every blade is packaged in a ...

Medicine Products:

Classic Trial Frames UB3 Adult Trial Frame Sickle Blade Rib Back